![Petter Veiby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petter Veiby
Gründer bei
ATTOVIA THERAPEUTICS, INC.
Vermögen: 1 $ am 31.07.2026
Profil
Petter Veiby is the founder of Attovia Therapeutics, Inc., founded in 2022, serving as Chief Scientific Officer.
Mr. Veiby is currently Director at BiVictriX Therapeutics Plc since 2025.
Former jobs include Senior Director at Millennium Pharmaceuticals, Inc. from 2022 to 2023, Global Head-Biotherapeutics at Millennium Pharmaceuticals, Inc. from 1999 to 2020, and Senior Vice President-Business Development at Immunitas Therapeutics, Inc. in 2022.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.08.2026 | 104 952 ( 0,24 % ) | 1 $ | 31.07.2026 |
Aktive Positionen von Petter Veiby
| Unternehmen | Position | Beginn |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Gründer | 16.12.2022 |
| BIVICTRIX THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.08.2025 |
Ehemalige bekannte Positionen von Petter Veiby
| Unternehmen | Position | Ende |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.06.2023 |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Corporate Officer/Principal | 01.11.2022 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.03.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
BiVictriX Therapeutics Plc
 BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
